ClinVar Miner

Submissions for variant NM_001079802.2(FKTN):c.330dup (p.Thr111fs)

dbSNP: rs767865405
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000378928 SCV000332847 pathogenic not provided 2015-07-22 criteria provided, single submitter clinical testing
GeneDx RCV000378928 SCV001812991 likely pathogenic not provided 2024-02-14 criteria provided, single submitter clinical testing Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 30564623)
Labcorp Genetics (formerly Invitae), Labcorp RCV001855091 SCV002236733 pathogenic Walker-Warburg congenital muscular dystrophy 2023-06-03 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 281839). This variant has not been reported in the literature in individuals affected with FKTN-related conditions. This variant is present in population databases (rs767865405, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.Thr111Tyrfs*13) in the FKTN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FKTN are known to be pathogenic (PMID: 17044012, 17878207, 18752264).
Fulgent Genetics, Fulgent Genetics RCV002487188 SCV002785081 likely pathogenic Dilated cardiomyopathy 1X; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4; Autosomal recessive limb-girdle muscular dystrophy type 2M; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1; Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4 2021-09-12 criteria provided, single submitter clinical testing
Counsyl RCV000412460 SCV000486169 likely pathogenic Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4 2016-04-08 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.